DENVER, Oct. 02, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, achieved a milestone in biotechnology; it has successfully mass-produced spider silk using silkworms, solving a challenge that eluded scientists and engineers for decades
For years, researchers have known that spider silk is stronger than steel by weight, stretchier than nylon, and biodegradable, a near-miraculous combination of properties. Yet despite decades of interest from the military, biomedical researchers, and textile designers, spider silk remained mostly out of reach.
Why? Spiders can’t be farmed. They’re territorial, solitary, and cannibalistic, making industrial spider silk production impossible through traditional farming.
Kraig Labs changed that.
Through advanced genetic engineering, the company’s proprietary silkworms now produce spider silk proteins as they spin, creating a scalable, cost-effective, and sustainable platform for spider silk production, using the same basic infrastructure as traditional silk.
Kraig’s breakthrough turns a biological curiosity into a functional supply chain, as its genetically engineered silkworms are the factory. This means spider silk can finally move from the lab into the real world, which opens it up to the world’s builders, scientists, and creators.
With consistent fiber quality, increasing yields, and commercial-scale facilities online, Kraig Labs is now positioned to make spider silk accessible to researchers and developers, which have expressed interest across industries:
- Inventors creating stronger, lighter wearables or materials
- Biomedical engineers prototyping biodegradable sutures and scaffolds
- Defense contractors designing next-generation body armor
- Outdoor brands seeking sustainable, high-performance textiles
- Robotics teams developing biomimetic actuators or tethers
The company is now opening the door to entirely new classes of material solutions.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.
For more information, please visit: www.kraiglabs.com
Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.
About 24/7 Market News
24/7 Market News (247) is a leading market news platform for public companies. As a pioneer in digital media, 247 is dedicated to the swift distribution of financial market news and information. 247 takes great pride in creating innovative public relations campaigns that help clients reach the target audience.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
